[How I treat young patients with multiple myeloma].
作者信息
Li J
机构信息
Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):465-468. doi: 10.3760/cma.j.issn.0253-2727.2017.06.001.
Abstract
摘要
相似文献
1
[How I treat young patients with multiple myeloma].[我如何治疗年轻的多发性骨髓瘤患者]
Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):465-468. doi: 10.3760/cma.j.issn.0253-2727.2017.06.001.
2
Shall we treat smoldering multiple myeloma in the near future?我们是否应该在不久的将来治疗冒烟型多发性骨髓瘤？
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):194-204. doi: 10.1182/asheducation-2017.1.194.
3
Pleural effusion in multiple myeloma.多发性骨髓瘤中的胸腔积液
Cancer. 1979 Sep;44(3):1150-4. doi: 10.1002/1097-0142(197909)44:3<1150::aid-cncr2820440353>3.0.co;2-u.
4
Multiple myeloma. An update on diagnosis and management.多发性骨髓瘤。诊断与管理的最新进展。
Acta Oncol. 1990;29(1):1-8. doi: 10.3109/02841869009089984.
5
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.贝兰他单抗马妥昔单抗治疗复发或难治性多发性骨髓瘤（DREAMM-2）：一项双臂、随机、开放标签、2 期研究。
Lancet Oncol. 2020 Feb;21(2):207-221. doi: 10.1016/S1470-2045(19)30788-0. Epub 2019 Dec 16.
6
Multiple myeloma and diagnostic imaging.多发性骨髓瘤与诊断性影像学
Radiol Technol. 2014 Mar-Apr;85(4):391-410; quiz 411-3.
7
Multiple myeloma in two young postpartum women.两名年轻产后女性患多发性骨髓瘤。
Arch Pathol Lab Med. 1987 Jan;111(1):38-42.
8
Multiple myeloma and systemic lupus erythematosus in a young woman.一名年轻女性患多发性骨髓瘤和系统性红斑狼疮。
J Clin Rheumatol. 2009 Sep;15(6):292-4. doi: 10.1097/RHU.0b013e3181b0fe1e.
9
New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.多发性骨髓瘤的新策略：免疫疗法作为治疗多发性骨髓瘤患者的新方法。
Clin Cancer Res. 2016 Dec 15;22(24):5959-5965. doi: 10.1158/1078-0432.CCR-16-0184. Epub 2016 Oct 19.
10
Smoldering multiple myeloma: to treat or not to treat.冒烟型多发性骨髓瘤：治疗与否
Expert Opin Pharmacother. 2015 Apr;16(6):785-90. doi: 10.1517/14656566.2015.1007952. Epub 2015 Feb 8.
本文引用的文献
1
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.多发性骨髓瘤修订国际分期系统：国际骨髓瘤工作组报告
J Clin Oncol. 2015 Sep 10;33(26):2863-9. doi: 10.1200/JCO.2015.61.2267. Epub 2015 Aug 3.
2
CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients?CD20 阳性多发性骨髓瘤：传统化疗能否仍用于使这些患者获得理想疗效？
Leuk Lymphoma. 2016 Feb;57(2):335-340. doi: 10.3109/10428194.2015.1055479. Epub 2015 Aug 28.
3
Autologous transplantation and maintenance therapy in multiple myeloma.自体移植和多发性骨髓瘤的维持治疗。
N Engl J Med. 2014 Sep 4;371(10):895-905. doi: 10.1056/NEJMoa1402888.
4
Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant.接受含硼替佐米方案治疗后行自体干细胞移植的多发性骨髓瘤患者中的乙型肝炎病毒再激活
Leuk Lymphoma. 2015 Jun;56(6):1710-7. doi: 10.3109/10428194.2014.941833. Epub 2015 Jan 14.
5
The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma.晚期和髓外多发性骨髓瘤的淋巴瘤样多药化疗方案“地塞米松-大剂量马法兰-阿糖胞苷-美法仑”
Ann Hematol. 2014 Jul;93(7):1207-14. doi: 10.1007/s00277-014-2023-2. Epub 2014 Feb 14.
6
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients.来那度胺、硼替佐米和地塞米松巩固和维持治疗高危骨髓瘤患者。
Leukemia. 2014 Mar;28(3):690-3. doi: 10.1038/leu.2013.335. Epub 2013 Nov 13.
7
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.多发性骨髓瘤患者的生存率持续提高：老年患者早期死亡率和结局的变化。
Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25.
8
Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials.硼替佐米为基础与非硼替佐米为基础的诱导治疗在前未经治疗多发性骨髓瘤患者自体造血干细胞移植前：III 期随机对照试验的荟萃分析。
J Clin Oncol. 2013 Sep 10;31(26):3279-87. doi: 10.1200/JCO.2012.48.4626. Epub 2013 Jul 29.
9
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.硼替佐米联合减低强度预处理方案及异基因造血干细胞移植治疗高危多发性骨髓瘤的Ⅱ期临床研究
Br J Haematol. 2013 Aug;162(4):474-82. doi: 10.1111/bjh.12410. Epub 2013 Jun 15.
10
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.新诊断有症状多发性骨髓瘤的治疗：2013 年 Mayo 多发性骨髓瘤分层和风险适应性治疗（mSMART）共识指南更新版。
Mayo Clin Proc. 2013 Apr;88(4):360-76. doi: 10.1016/j.mayocp.2013.01.019.
Zotero 插件